business-and-industry 
STAT
APRIL 29, 2024
The pharmaceutical industry saw its reputation slip last year among patient advocacy groups thanks to growing concern about the rising prices for medicines and a lack of confidence prompted by increasing shortages, according to a new survey.
STAT
APRIL 23, 2024
The Federal Trade Commission approved a far-reaching noncompete ban Tuesday that could force sweeping changes across the health care industry. Crucially for the health care industry, the noncompete ban does not apply to nonprofit companies, as the FTC determined it only has jurisdiction over for-profit companies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 4, 2024
The gathering resembled something of a fact-finding mission as a small group of policymakers and business people briefly shared their experiences dealing with the largest industry middlemen, who negotiate with drugmakers on behalf of insurers and employers and, in the process, create formularies or lists of medicines that are covered by insurance.
STAT
APRIL 18, 2024
WASHINGTON — In the photo, the two men are grinning widely: the CEO of WuXi Biologics and the incoming CEO of the biotechnology industry’s largest trade group. biotechs from doing business with the Chinese behemoth. biotechs from doing business with the Chinese behemoth.
STAT
MARCH 14, 2024
Rise and shine, everyone, another busy day is on the way. This is an especially busy day for us, in fact, since we are hosting a session later on biosimilars — mark your calendar for 1 p.m. biotechnology industry will have to make do without a company that it has come to heavily rely on for developing and making drugs.
STAT
MARCH 13, 2024
WASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese company WuXi in response to increasing U.S. biotechnology industry will have to make do without a company that it has come to heavily rely on for developing and making drugs.
STAT
APRIL 18, 2024
The company was once an industry darling, its star rising — and then falling — with the consumer genetics boom of the 2010s. The company was once an industry darling, its star rising — and then falling — with the consumer genetics boom of the 2010s. Continue to STAT+ to read the full story…
Expert insights. Personalized for you.
279 
Let's personalize your content